BIVALIRUDIN J Code: J0582

Drug & Product Overview

HCPCS Descriptor Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg

HCPCS Added Date October 1, 2025

Manufacturer Endo USA

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About BIVALIRUDIN

Bivalirudin is a medication aligned to the HCPCS J Code: J0582 for billing, pricing, and reimbursement purposes in the United States. This Cardiology medication is administered via the intravenous route and manufactured by Endo USA.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
42023-0622-10	Bivalirudin	Par Health USA, LLC	2500	250 MG
•••••-••••-•• Log in to view	BIVALIRUDIN

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BIVALIRUDIN Pricing & Reimbursement

J0582 Private Payer Reimbursement

$0.14 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Bivalirudin 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J0582	Endo USA	Bivalirudin	Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
J0583	Generic Code (Multiple Manufacturers)	Bivalirudin	Injection, bivalirudin, 1 mg

BIVALIRUDIN CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

BIVALIRUDIN Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Percutaneous Coronary Intervention (PCI)

Drug Class

Anti-coagulant [EPC]Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]

Frequently Asked Questions

Is there an available Bivalirudin billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for Bivalirudin.

Are there any available Bivalirudin patient assistance programs?

Our team has not identified a manufacturer-published source of patient assitance information for Bivalirudin.

Where can I find Bivalirudin prescribing information?

Bivalirudin prescribing information can be found through the link below. Visit Here →

Where can I find Bivalirudin side effect information?

Our team has not yet identified a source of prescribing information for Bivalirudin.

Does billing Bivalirudin require wastage modifiers?

CMS does not include BIVALIRUDIN (J0582) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0582. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.